Drug distributor McKesson missed estimates for third-quarter revenue on Wednesday, hurt by less-than-expected sales in its ...

McKesson Corporation MCK reported third-quarter fiscal 2025 adjusted earnings per share (EPS) of $8.03, which missed the ...

McKesson Corporation (NYSE: MCK) has released its fiscal 2025 third quarter financial results. Results can be accessed on ...

Healthcare distributor and services company McKesson (NYSE:MCK) in Q4 CY2024, but sales rose 17.8% year on year to $95.29 ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Viking Therapeutics (VKTX – Research Report) and ...

After the purchase concludes, the firm intends to include PRISM Vision into its U.S. Pharmaceutical division subject to ...

Based on our third quarter performance, we are raising and narrowing our guidance range for fiscal 2025 Adjusted Earnings per Diluted Share to $32.55 to $32.95. We are also pleased to announce the ...

McKesson inked a deal to buy a controlling interest in Prism Vision Holdings, as it also logged higher profit and revenue in its fiscal third quarter. The drug distributor said Wednesday that it ...

Welcome to McKesson's Third Quarter Fiscal 2025 Earnings Conference Call. Please be advised that today's conference is being recorded. At this time, I'd like to turn the conference over to Rachel ...

Irving-based McKesson (NYSE: MCK) announced on Feb. 4 an agreement to buy an 80% controlling interest in New Providence, New ...

IRVING, Texas (AP) — IRVING, Texas (AP) — McKesson Corp. (MCK) on Wednesday reported fiscal third-quarter earnings of $879 million. The Irving, Texas-based company said it had profit of $6.95 per ...

McKesson Corp (MCK) reports an 18% revenue increase and raises EPS guidance amid strategic investments and acquisitions.